Previous studies have demonstrated the ability of anti‐mesothelin adoptive cell therapies using CAR T43, 44, 45, 46 and CAR NK cells,47 to specifically target and kill MSLN‐positive gastric and colorectal tumour cells. Here, MSLN is linked to colorectal neoplasm.